{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:47:27Z","timestamp":1790790447993,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Melanomas &amp;lt; 0.8\u2005mm in Breslow depth have less than\u00a0a 5% risk for nodal positivity. Nonetheless, nodal positivity is prognostic for this group. Early identification of nodal positivity may improve the outcomes for these patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine the degree to which ulceration and other high-risk features predict sentinel lymph node (SLN) positivity for very thin melanomas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The National Cancer Database was reviewed from 2012 to 2018 for patients with melanoma with Breslow thickness &amp;lt; 0.8\u2005mm. Data were analysed from 7 July 2022 through to 25 February 2023. Patients were excluded if data regarding their ulceration status or SLN biopsy (SLNB) performance were unknown. We analysed patient, tumour and health system factors for their effect on SLN positivity. Data were analysed using \u03c72 tests and logistic regressions. Overall survival (OS) was compared by Kaplan\u2013Meier analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Positive nodal metastases were seen in 876 (5.0%) patients who underwent SLNB (17 692). Factors significantly associated with nodal positivity on multivariable analysis include lymphovascular invasion [odds ratio (OR) 4.5, P &amp;lt; 0.001], ulceration (OR 2.6, P &amp;lt; 0.001), mitoses (OR 2.1, P &amp;lt; 0.001) and nodular subtype (OR 2.1, P &amp;lt; 0.001). Five-year OS was 75% and 92% for patients with positive and negative SLN, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Nodal positivity has prognostic significance for very thin melanomas. In our cohort, the rate of nodal positivity was 5% overall in these patients who underwent SLNB. Specific tumour factors (e.g. lymphovascular invasion, ulceration, mitoses, nodular subtype) were associated with higher rates of SLN metastases and should be used to guide clinicians in choosing which patients will benefit from SLNB.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljad195","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:42:01Z","timestamp":1686271321000},"page":"419-426","source":"Crossref","is-referenced-by-count":11,"title":["Predictors of sentinel lymph node metastasis in very thin invasive melanomas"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1282-5443","authenticated-orcid":false,"given":"Hanna","family":"Kakish","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David X","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasih Ali","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamedraed","family":"Elshami","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W","family":"Loftus","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M","family":"Ocuin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Ammori","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Hoehn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S","family":"Bordeaux","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke D","family":"Rothermel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center , 11100 Euclid Ave., Cleveland, OH,\u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"2023122117352935600_ljad195-B1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2023122117352935600_ljad195-B2","author":"Swetter"},{"key":"2023122117352935600_ljad195-B3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archsurg.143.9.892","article-title":"Importance of sentinel lymph node biopsy in patients with thin melanoma","volume":"143","author":"Wright","year":"2008","journal-title":"Arch Surg"},{"key":"2023122117352935600_ljad195-B4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1245\/ASO.2006.04.023","article-title":"The prognostic importance of sentinel lymph node biopsy in thin melanoma","volume":"13","author":"Ranieri","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"2023122117352935600_ljad195-B5","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-012-2826-0","article-title":"Sentinel node biopsy in thin and thick melanoma","volume":"20","author":"Mozzillo","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2023122117352935600_ljad195-B6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/SLA.0b013e3182306c72","article-title":"Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma","volume":"255","author":"Murali","year":"2012","journal-title":"Ann Surg"},{"key":"2023122117352935600_ljad195-B7","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma","volume":"31","author":"Han","year":"2013","journal-title":"J Clin Oncol"},{"key":"2023122117352935600_ljad195-B8","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1200\/JCO.2013.54.2340","article-title":"Prediction of survival in patients with thin melanoma: results from a multi-institution study","volume":"32","author":"Maurichi","year":"2014","journal-title":"J Clin Oncol"},{"key":"2023122117352935600_ljad195-B9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jso.26723","article-title":"More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: a Danish population-based study of 7148 patients","volume":"125","author":"Weitemeyer","year":"2022","journal-title":"J Surg Oncol"},{"issue":"11\u00a0Suppl.\u00a01","key":"2023122117352935600_ljad195-B10","first-page":"s3","article-title":"A dermatologist\u2019s guide to implementation of gene expression profiling in the management of melanoma","volume":"13","author":"Kwatra","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"2023122117352935600_ljad195-B11","doi-asserted-by":"crossref","DOI":"10.2217\/mmt-2019-0016","article-title":"Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice","volume":"6","author":"Grossman","year":"2019","journal-title":"Melanoma Manag"},{"key":"2023122117352935600_ljad195-B12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/CMR.0000000000000489","article-title":"Stage-specific incidence trends of melanoma in an English region, 1996\u20132015: longitudinal analyses of population-based data","volume":"30","author":"Herbert","year":"2020","journal-title":"Melanoma Res"},{"key":"2023122117352935600_ljad195-B13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2008.08641.x","article-title":"An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5\u2005mm thick at diagnosis","volume":"159","author":"Einwachter-Thompson","year":"2008","journal-title":"Br J Dermatol"},{"key":"2023122117352935600_ljad195-B14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.suronc.2016.05.020","article-title":"Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: a cost-effectiveness analysis","volume":"25","author":"Serra-Arbeloa","year":"2016","journal-title":"Surg Oncol"},{"key":"2023122117352935600_ljad195-B15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0039-6060(03)00275-7","article-title":"Cost-effectiveness of sentinel lymph node biopsy in thin melanomas","volume":"134","author":"Agnese","year":"2003","journal-title":"Surgery"},{"key":"2023122117352935600_ljad195-B16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","article-title":"Complications of sentinel lymph node biopsy for melanoma \u2013 a systematic review of the literature","volume":"43","author":"Moody","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"2023122117352935600_ljad195-B17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ejso.2004.06.021","article-title":"Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free","volume":"30","author":"Wasserberg","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"2023122117352935600_ljad195-B18","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1002\/cam4.2358","article-title":"Survival analysis and sentinel lymph node status in thin cutaneous melanoma: a multicenter observational study","volume":"8","author":"Tejera-Vaquerizo","year":"2019","journal-title":"Cancer Med"},{"key":"2023122117352935600_ljad195-B19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg"},{"key":"2023122117352935600_ljad195-B20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","article-title":"Incident cases captured in the national cancer database compared with those in U.S. population based central cancer registries in 2012\u20132014","volume":"26","author":"Mallin","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2023122117352935600_ljad195-B21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.surg.2018.10.035","article-title":"Disparities in utilization of treatment for clinical stage I\u2013II pancreatic adenocarcinoma by area socioeconomic status and race\/ethnicity","volume":"165","author":"Swords","year":"2019","journal-title":"Surgery"},{"key":"2023122117352935600_ljad195-B22","author":"American College of Surgeons"},{"key":"2023122117352935600_ljad195-B23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamadermatol.2017.2497","article-title":"Association between patient age and lymph node positivity in thin melanoma","volume":"153","author":"Sinnamon","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2023122117352935600_ljad195-B24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9610(02)01102-9","article-title":"Patterns of early recurrence after sentinel lymph node biopsy for melanoma","volume":"184","author":"Chao","year":"2002","journal-title":"Am J Surg"},{"key":"2023122117352935600_ljad195-B25","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"2023122117352935600_ljad195-B26","doi-asserted-by":"crossref","first-page":"e2452","DOI":"10.1097\/MD.0000000000002452","article-title":"Long-term survival of patients with invasive ultra-thin cutaneous melanoma: a single-center retrospective analysis","volume":"95","author":"Vecchiato","year":"2016","journal-title":"Medicine"},{"key":"2023122117352935600_ljad195-B27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaad.2013.07.016","article-title":"A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas","volume":"69","author":"Cooper","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2023122117352935600_ljad195-B28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/CMR.0000000000000143","article-title":"The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma","volume":"25","author":"Hieken","year":"2015","journal-title":"Melanoma Res"},{"key":"2023122117352935600_ljad195-B29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejso.2018.11.022","article-title":"Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases","volume":"45","author":"Piazzalunga","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2023122117352935600_ljad195-B30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ans.15804","article-title":"Regional nodal metastasis and 5-year survival in patients with thin melanoma in Queensland: a population-based study","volume":"90","author":"Theile","year":"2020","journal-title":"ANZ J Surg"},{"key":"2023122117352935600_ljad195-B31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2022.09.040","article-title":"Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: a multicenter cohort study","volume":"88","author":"Shannon","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2023122117352935600_ljad195-B32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/0194599817741641","article-title":"Clinicopathologic factors predictive of occult lymph node involvement in cutaneous head and neck melanoma","volume":"158","author":"Yalamanchi","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2023122117352935600_ljad195-B33","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/cam4.922","article-title":"Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy","volume":"5","author":"Rubinstein","year":"2016","journal-title":"Cancer Med"},{"key":"2023122117352935600_ljad195-B34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00259-011-2009-4","article-title":"Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness &lt; 1.00\u2005mm) on the basis of a long-term follow-up","volume":"39","author":"Hinz","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023122117352935600_ljad195-B35","first-page":"16","article-title":"Racial and ethnic healthcare disparities in skin cancer in the United States: a review of existing inequities, contributing factors, and potential solutions","volume":"15","author":"Shao","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"2023122117352935600_ljad195-B36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10900-010-9328-4","article-title":"Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities","volume":"36","author":"Wich","year":"2011","journal-title":"J Community Health"},{"key":"2023122117352935600_ljad195-B37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1245\/ASO.2006.05.011","article-title":"Predictors of regional nodal disease in patients with thin melanomas","volume":"13","author":"Karakousis","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"2023122117352935600_ljad195-B38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/ASO.2005.04.027","article-title":"Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas","volume":"12","author":"Kesmodel","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"2023122117352935600_ljad195-B39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1245\/s10434-013-3313-y","article-title":"Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy","volume":"21","author":"Bartlett","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2023122117352935600_ljad195-B40","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2012.08.045","article-title":"Analysis of sentinel lymph node positivity in patients with thin primary melanoma","volume":"68","author":"Venna","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2023122117352935600_ljad195-B41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.suronc.2010.11.001","article-title":"Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study","volume":"20","author":"Quaglino","year":"2011","journal-title":"Surg Oncol"},{"key":"2023122117352935600_ljad195-B42","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1245\/s10434-021-10038-6","article-title":"Sentinel lymph node biopsy for thin melanoma \u2013 some need it, some don\u2019t. So now what?","volume":"28","author":"Egger","year":"2021","journal-title":"Ann Surg Oncol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljad195\/50960233\/ljad195.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/4\/419\/54726744\/ljad195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/4\/419\/54726744\/ljad195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T19:18:27Z","timestamp":1703186307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/189\/4\/419\/7192420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,6,8]]},"published-print":{"date-parts":[[2023,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljad195","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,6,8]]}}}